EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer

Jan Tkac iD, Veronika Gajdosova, Stefania Hroncekova, Tomas Bertok, Michal Hires, Eduard Jane, Lenka Lorencova, Peter Kasak

Interface Focus · 06.04.2019 · 9 (2) · 20180077

DOI: 10.1098/rsfs.2018.0077 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Interface Focus, online erschienen am 15.02.2019. Verfasst von Jan Tkac und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 9, 84538 Bratislava, Slovakia. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: H2020 European Research Council, Agentúra Ministerstva školstva, vedy, výskumu a športu SR, Agentúra na Podporu Výskumu a Vývoja.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, thereby considerably reducing the number of unnecessary biopsies. In addition, PSA glycoprofiling can serve as a prognostic PCa biomarker to identify PCa patients with an aggressive form of PCa, avoiding unnecessary further treatments which are significantly life altering (incontinence or impotence).

Schlagwörter

Stichwörter der Autor:innen

biomarkersdiagnosticsglycanslectinsprostate cancerprostate-specific antigen

Autor:innen und Institutionen

  • Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 9, 84538 Bratislava, Slovakia.
  • Glycanostics Ltd, Dubravska cesta 9, 84538 Bratislava, Slovakia.
  • Center for Advanced Materials, Qatar University, Doha 2713, Qatar.

ORCID-Profile: Jan Tkac

Förderung

  • H2020 European Research Council
  • Agentúra Ministerstva školstva, vedy, výskumu a športu SR
  • Agentúra na Podporu Výskumu a Vývoja
  • Horizon 2020 Framework Programme
  • European Regional Development Fund

Zitieren

APA

Tkac, J., Gajdosova, V., Hroncekova, S., Bertok, T., Hires, M., Jane, E., Lorencova, L., & Kasak, P. (2019). Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer. Interface Focus, 9(2), 20180077. https://doi.org/10.1098/rsfs.2018.0077

Vancouver

Tkac J, Gajdosova V, Hroncekova S, Bertok T, Hires M, Jane E, et al. Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer. Interface Focus. 2019;9(2):20180077. doi:10.1098/rsfs.2018.0077

BibTeX
@article{Tkac2019,
  author = {Tkac, Jan and Gajdosova, Veronika and Hroncekova, Stefania and Bertok, Tomas and Hires, Michal and Jane, Eduard and Lorencova, Lenka and Kasak, Peter},
  title = {Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer},
  journal = {Interface Focus},
  year = {2019},
  volume = {9},
  number = {2},
  pages = {20180077},
  doi = {10.1098/rsfs.2018.0077}
}
Kostenlos starten →